Arsenic Trioxide Suppressed Migration and Angiogenesis by Targeting FOXO3a in Gastric Cancer Cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Arsenic Trioxide Suppressed Migration and Angiogenesis by Targeting FOXO3a in Gastric Cancer Cells
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 12, Pages 3739
Publisher
MDPI AG
Online
2018-11-26
DOI
10.3390/ijms19123739
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Arsenic trioxide attenuates STAT-3 activity and epithelial-mesenchymal transition through induction of SHP-1 in gastric cancer cells
- (2018) Sung Ho Kim et al. BMC CANCER
- Low dosage of arsenic trioxide (As2O3) inhibits angiogenesis in epithelial ovarian cancer without cell apoptosis
- (2018) Dehong Luo et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Role of Forkhead Box Class O proteins in cancer progression and metastasis
- (2018) Chang Geun Kim et al. SEMINARS IN CANCER BIOLOGY
- The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance
- (2018) Shang Yao et al. SEMINARS IN CANCER BIOLOGY
- FOXO3 Inhibits Human Gastric Adenocarcinoma (AGS) Cell Growth by Promoting Autophagy in an Acidic Microenvironment
- (2018) Yuan Gao et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Critical role of FOXO3a in carcinogenesis
- (2018) Ying Liu et al. Molecular Cancer
- Convergence of VEGF and YAP/TAZ signaling: Implications for angiogenesis and cancer biology
- (2018) Ameer L. Elaimy et al. Science Signaling
- Downregulation of FOXO6 in breast cancer promotes epithelial–mesenchymal transition and facilitates migration and proliferation of cancer cells
- (2018) Hui Ye et al. Cancer Management and Research
- VEGF as a potential target in lung cancer
- (2017) Daniela Frezzetti et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis
- (2017) Zhongrun Qian et al. INTERNATIONAL JOURNAL OF CANCER
- Angiogenesis and Anti-Angiogenic Therapy in Gastric Cancer
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Arsenic trioxide is an immune adjuvant in liver cancer treatment
- (2017) Lei Wang et al. MOLECULAR IMMUNOLOGY
- Swallowing a bitter pill–oral arsenic trioxide for acute promyelocytic leukemia
- (2016) Pallawi Torka et al. BLOOD REVIEWS
- Forkhead Transcription Factor 3a (FOXO3a) Modulates Hypoxia Signaling via Up-regulation of the von Hippel-Lindau Gene (VHL)
- (2016) Xing Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- FoxO3a mediates glioma cell invasion by regulating MMP9 expression
- (2016) Ke Xu et al. ONCOLOGY REPORTS
- NF-κB–driven suppression of FOXO3a contributes to EGFR mutation-independent gefitinib resistance
- (2016) Ching-Feng Chiu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- FOXO3a Expression Regulated by ERK Signaling is Inversely Correlated With Y-Box Binding Protein-1 Expression in Prostate Cancer
- (2016) Kenjiro Imada et al. PROSTATE
- FOXO transcription factors in cancer development and therapy
- (2015) Alexandra Coomans de Brachène et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- FOXO3a modulates WNT/β-catenin signaling and suppresses epithelial-to-mesenchymal transition in prostate cancer cells
- (2015) Hao Liu et al. CELLULAR SIGNALLING
- Angiogenesis inhibitors in gastric and gastroesophageal junction cancer
- (2015) Giandomenico Roviello et al. Gastric Cancer
- Downregulation of FOXO3a Promotes Tumor Metastasis and Is Associated with Metastasis-Free Survival of Patients with Clear Cell Renal Cell Carcinoma
- (2014) D. Ni et al. CLINICAL CANCER RESEARCH
- Arsenic Trioxide Exerts Anti-lung Cancer Activity by Inhibiting Angiogenesis
- (2014) Meng-Hang Yang et al. CURRENT CANCER DRUG TARGETS
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Inactivation of Akt by arsenic trioxide induces cell death via mitochondrial-mediated apoptotic signaling in SGC-7901 human gastric cancer cells
- (2014) YAN-HUI GAO et al. ONCOLOGY REPORTS
- Metformin Induces Apoptosis and Cell Cycle Arrest Mediated by Oxidative Stress, AMPK and FOXO3a in MCF-7 Breast Cancer Cells
- (2014) Eveline A. I. F. Queiroz et al. PLoS One
- Arsenic Trioxide-Induced Growth Arrest of Breast Cancer MCF-7 Cells Involving FOXO3a and IκB Kinase β Expression and Localization
- (2012) Wenlou Liu et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Foxo3a: An integrator of immune dysfunction during HIV infection
- (2012) Julien van Grevenynghe et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Therapeutic targeting of VEGF in the treatment of glioblastoma
- (2012) Lizbeth Robles Irizarry et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Arsenic Trioxide Inhibits Cell Growth and Induces Apoptosis through Inactivation of Notch Signaling Pathway in Breast Cancer
- (2012) Jun Xia et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Deciphering the Role of Forkhead Transcription Factors in Cancer Therapy
- (2011) Jer-Yen Yang et al. CURRENT DRUG TARGETS
- Arsenic trioxide inhibits invasion/migration in SGC-7901 cells by activating the reactive oxygen species-dependent cyclooxygenase-2/matrix metalloproteinase-2 pathway
- (2011) Yingxia Liu et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Genistein potentiates the effect of arsenic trioxide against human hepatocellular carcinoma: Role of Akt and nuclear factor-κB
- (2010) Yong Ma et al. CANCER LETTERS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started